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Abstract Stimulation of bovine polymorphonuclear leukocytes
(PMN) with serum-opsonized zymosan (sOZ) induced the
activation of p38 mitogen-activated protein kinase (MAPK),
protein kinase C (PKC) and phosphatidylinositol 3-kinase (PI3-
K) and sOZ-induced O32 production was significantly attenuated
by their inhibitors (SB203580 for p38 MAPK, GF109203X for
PKC and wortmannin for PI3-K). They caused significant
attenuation of sOZ-induced phosphorylation of p47phox as well.
Flow cytometric analysis, however, revealed that SB203580 and
wortmannin attenuated phagocytosis, but GF109203X facilitated
it. The results suggest that p38 MAPK and PI3-K participated in
both signaling pathways of NADPH oxidase activation (O32
production) and phagocytosis, and PKC participated in the
signaling pathway of NADPH oxidase activation alone.
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1. Introduction
Polymorphonuclear leukocytes (PMN) play an important
role in host defense against bacterial infections. The bacter-
icidal mechanism consists of phagocytosis of pathogens, gen-
eration of reactive oxygen intermediates (ROI), and release of
bactericidal proteins to phagosomes. During the bactericidal
responses, phagosomes contain a variety of ROI, including
OCl3, bOH and H2O2, which are derivatives of O32 generated
from oxygen by NADPH oxidase [1]. NADPH oxidase is a
multicomponent enzyme consisting of at least two membrane
proteins (gp91phox and p22phox) and three cytosolic proteins
(p47phox, p67phox and Rac). When PMN are exposed to the
appropriate stimuli, NADPH oxidase is activated by associat-
ing with these components on the plasma membrane followed
by O32 production [2]. Phagocytosis is the process that recog-
nizes the infectious agents and engulfs them, and thereby sep-
arates these organisms from normal tissue. Receptors partic-
ipating in the NADPH oxidase activation and phagocytosis
include the IgG Fc receptor (FcQR) and L2-integrin receptor
(CR3, CD11b/CD18), which binds to iC3b [3^5].
FcQR and CR3 act cooperatively to stimulate the intracel-
lular signaling pathways not only to initiate the actin poly-
merization necessary for phagocytosis but also to activate
NADPH oxidase for O32 production [6,7]. Recently, some
components of the signaling pathways associated with the
PMN responses were identi¢ed. Cross-linking of FcQRs indu-
ces the activation of src family tyrosine kinases followed by
the activation of Syk tyrosine kinase [8]. Tyrosine phosphor-
ylation of FcQR by src family tyrosine kinases is an important
process for phagocytosis in macrophages and FcQR-trans-
fected cells, and PMN defective in Syk tyrosine kinase exhibits
signi¢cant decreases in phagocytosis and O32 production [9^
11]. Cross-linking of FcQRs also stimulates the tyrosine phos-
phorylation of phospholipase CQ, which leads to an increase
in the concentration of intracellular calcium and the produc-
tion of diacylglycerol, an activator of protein kinase C (PKC)
[12,13]. PKC inhibition prevents O32 production in PMN [6]
and attenuates phagocytosis in monocytes and PMN [14,15].
However, the phagocytosis in macrophages is not a¡ected by
this treatment [11]. Phosphatidylinositol 3-kinase (PI3-K) ac-
tivation as well as tyrosine kinase activation was reported to
occur after PMN stimulation and to be associated with both
O32 production and phagocytosis in PMN [16,17].
p38 Mitogen-activated protein kinase (MAPK) is a Ser/Thr
kinase belonging to the family of MAPKs and its importance
in PMN was recently demonstrated. Stimulation of FcQR and
CR3 activates the p38 MAPK in macrophages and PMN
[18,19]. In£ammatory stimuli, including lipopolysaccharide
(LPS) and N-formyl-methionyl-leucyl-phenylalanine (fMLP),
also activate p38 MAPK and a speci¢c inhibitor of p38
MAPK prevents O32 production in PMN when exposed to
fMLP and LPS [20,21]. Several papers have suggested that
p38 MAPK was involved in the signaling pathway of O32
production. However, its role in phagocytosis is still uncer-
tain. In this study, we examined the roles of p38 MAPK, PKC
and PI3-K in the signaling pathways leading to not only O32
production but also phagocytosis using various pharmacolog-
ical inhibitors.
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2. Materials and methods
2.1. Materials
Zymosan, horseradish peroxidase, adenosine, ATP, phosphatidyl-
inositol, and glutathione (GSH)-agarose were purchased from Sigma
Chemical Co. (St. Louis, MO, USA). GF109203X, wortmannin, and
SB203580 were from Calbiochem (La Jolla, CA, USA). Protein A-
agarose, anti-PKC antibody and anti-phosphotyrosine antibody (PY-
20) were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA,
USA). Anti-phosphorylated p38 MAPK antibody was from New
England Biolabs, Inc. (Beverly, MA, USA). Silica gel 60 F254 was
from Merck KGaA (Darmstadt, Germany). Luminol was from
Wako Pure Chemicals Industries, Ltd. (Osaka, Japan). [Q-32P]ATP
was from ICN Biomedicals Inc. (Costa Mesa, CA, USA). Ca2-
and Mg2-free Hanks’ balanced salt solution (HBSS(3)) and isopro-
pyl thio-L-galactoside (IPTG) were from Gibco BRL (Grand Island,
NY, USA). Fluorescent polystyrene latex particles (1.0 Wm diameter)
were obtained from Polysciences, Inc. (Warrington, PA, USA).
2.2. PMN isolation
Peripheral blood was obtained from clinically healthy cows and
suspended in HBSS(3). The suspension was layered on Ficoll^Conray
solution and centrifuged at 3000 rpm for 30 min at 20‡C. After re-
moval of plasma and monocytes, the pellet was suspended in 0.8%
NH4Cl and incubated for 10 min at 4‡C to lyse erythrocytes. Cells
were collected by centrifugation at 1200 rpm for 10 min at 4‡C and
washed with HBSS(3). Isolated cells were suspended in HBSS(3).
Viability was always more than 95% by the dye exclusion test with
trypan blue.
2.3. Preparation of serum-opsonized zymosan (sOZ)
Zymosan was suspended in fresh autologous serum at a concentra-
tion of 10 mg/ml and incubated for 30 min at 37‡C. After incubation,
the suspension was washed twice with HBSS(3) and resuspended in
HBSS(3) at a concentration of 10 mg/ml.
2.4. Immunoblotting for activated p38 MAPK
PMN (5U106) were preincubated in HBSS(+) at 37‡C for 5 min
before addition of sOZ at 1 mg/ml. After stimulation at 37‡C for
indicated times, reactions were terminated by adding 1 ml of ice-
cold HBSS(3) and subsequent centrifugation at 6000 rpm for 30 s
at 4‡C. Subsequently, cell pellets were suspended with 50 Wl of lysis
bu¡er (1% Triton X-100, 20 mM Tris^HCl [pH 8.0], 100 mM NaCl,
10 mM Na2P2O7, 2 mM EDTA, 50 mM NaF, 10% (v/v) glycerol,
1 mM Na3VO4, 10 Wg/ml aprotinin, 10 Wg/ml leupeptin, 1 mM
phenylmethylsulfonyl £uoride (PMSF)) and sonicated (15 sU2). After
centrifugation at 12 000 rpm for 15 min at 4‡C, 15 Wl of 3ULaemmli
sample bu¡er was added to 30 Wl of supernatant and boiled for 5 min.
Each sample containing 75 Wg of cellular protein was subjected to 10%
SDS^PAGE and then transferred to a nitrocellulose membrane. The
membrane was incubated with anti-phosphorylated p38 MAPK anti-
body diluted 1/1000 in TBST (10 mM Tris^HCl [pH 7.4], 0.1 M NaCl,
0.1% Tween-20) containing 5% bovine serum albumin, and then HRP-
conjugated anti-rabbit IgG. After three washes with TBST, bound
antibody was detected with a chemiluminescence detection kit (Boehr-
inger Mannheim GmbH, Mannheim, Germany).
2.5. PKC translocation
PMN (3.5U107) were treated as described above. After stimulation,
cell pellets were suspended in modi¢ed relaxation bu¡er (100 mM
KCl, 3 mM NaCl, 3.5 mM MgCl2, 10 mM PIPES [pH 7.4], 1 mM
PMSF, 10 Wg/ml leupeptin, 10 Wg/ml aprotinin) and then sonicated at
4‡C (20 sU3). Nuclei, granules and unbroken cells were removed by
centrifugation at 2500 rpm for 10 min at 4‡C. The supernatant was
centrifuged at 42 000 rpm for 30 min at 4‡C to separate cytosol and
membrane fractions. The pellet (membrane) was dissolved in
1ULaemmli sample bu¡er and boiled for 5 min. Each sample con-
taining 30 Wg of membrane protein was subjected to 7.5% SDS^PAGE
and then transferred to a nitrocellulose membrane. Blocking, treat-
ment with the primary and secondary antibodies and visualization
were similar to the procedures used for p38 MAPK.
2.6. Measurement of PI3-K activity
PMN (1U107) were treated as described above. After stimulation,
cell pellets were lysed for 30 min at 4‡C with 1 ml of lysis bu¡er and
centrifuged at 12 000 rpm for 30 min at 4‡C to remove insoluble
debris. The supernatant was precleared by incubation with protein
A-agarose for 30 min at 4‡C before immunoprecipitation. The mea-
surement of PI3-K activity was performed by the method of Co¡er et
al. [22]. Brie£y, the precleared lysates were incubated with 2 Wg of
anti-phosphotyrosine monoclonal antibody (PY-20) on a rotating
wheel for 1 h at 4‡C before the addition of 40 Wl of a 50% slurry of
protein A-agarose and further incubated for 1 h. The samples were
washed three times with lysis bu¡er and twice with 10 mM Tris^HCl
(pH 7.4) containing 1 mM Na3VO4. PI3-K activity was measured by
adding 100 Wg of sonicated phosphatidylinositol and 10 WCi of
[Q-32P]ATP in the presence of 200 WM adenosine (to inhibit phospha-
tidylinositol 4-kinase activity), 30 mM MgCl2 and 35 WM ATP in a
total volume of 60 Wl. Reactions were performed for 20 min at 25‡C
and terminated by the addition of 100 Wl of 1 M HCl and 200 Wl of
chloroform/methanol (1:1, v/v). After centrifugation at 3000 rpm for
5 min and removal of the upper layer, 80 Wl of methanol/HCl (1:1)
was added. After further centrifugation, lipids were separated on TLC
plates (silica gel 60 F254) with a solvent system of chloroform/meth-
anol/H2O/NH4OH (45:35:7.5:2.5, v/v). The radioactivities on the
TLC plates were visualized and analyzed with an imaging analyzer
(Fujix BAS1000; Fuji Photo Film Co., Ltd., Tokyo, Japan).
2.7. Assay of O32 production
O32 production was measured by chemiluminescence with luminol.
HBSS with 0.5 mM CaCl2 and 1 mM MgCl2 (HBSS[+]) containing
3U106 PMN, 10 WM luminol and 50 Wg/ml of horseradish peroxidase
was prepared in each well of a 96-well microplate. The suspension,
with a volume of 315 Wl, was incubated for 5 min at 37‡C. After
incubation, PMN were activated by adding 35 Wl of sOZ (10 mg/ml)
and then chemiluminescence from each well was measured by lumin-
ometer (Luminescencer-JNR; ATTO Co., Tokyo, Japan) for 0.5 s at
37‡C.
2.8. Recombinant p47phox fusion protein and kinase assay
Recombinant p47phox fusion protein as a substrate for kinases was
prepared with the procedure described by Park and Babior [23].
Brie£y, Escherichia coli transformed with pGEX-1VT containing an
insert of p47phox cDNA were grown in the presence of 1 mM IPTG
and lysed. The glutathione S-transferase (GST)^p47phox fusion pro-
tein in the cell lysate was puri¢ed on GSH-agarose. The purity and
identity of the fusion protein were assayed by 10% SDS^PAGE and
immunoblotting.
PMN (2U107) in HBSS(+) were incubated for 5 min at 37‡C and
then stimulated with 1 mg/ml of sOZ for the indicated lengths of time
at 37‡C. The reaction was terminated by centrifugation at 3000 rpm
for 5 min at 4‡C. The supernatant was removed and cells were sus-
pended in 50 Wl of ice-cold WCE bu¡er (20 mM HEPES [pH 7.7], 75
mM NaCl, 2.5 mM MgCl2, 0.1 mM EDTA, 0.05% Triton X-100, 0.5
mM dithiothreitol (DTT), 20 mM L-glycerophosphate, 0.1 mM
Na3VO4, 2 Wg/ml of leupeptin, 100 Wg/ml of PMSF). Cells were
then sonicated and the extracts were obtained by centrifugation at
12 000 rpm for 10 min at 4‡C. The extracts were mixed with 75 Wl
of GSH-agarose suspension to which 15 Wg of GST^p47phox was
bound. The mixture was rotated for 3 h at 4‡C and pelleted by cen-
trifugation at 10 000 rpm for 20 s. After the agarose beads were
washed four times with HEPES binding bu¡er (20 mM HEPES [pH
7.7], 50 mM NaCl, 2.5 mM MgCl2, 0.1 mM EDTA, 0.05% Triton X-
100), they were resuspended in 30 Wl of kinase bu¡er (20 mM HEPES
[pH 7.6], 20 mM MgCl2, 20 mM L-glycerophosphate, 0.1 mM
Na3VO4, 2 mM DTT) containing 20 WM ATP and 10 WCi of
[Q-32P]ATP. After incubation for 20 min at 30‡C, the reaction was
terminated by washing with HEPES binding bu¡er. Laemmli sample
bu¡er (1U, 45 Wl) was added to the beads, which were boiled to
separate p47phox^GST from them. The separated p47phox^GST
was subjected to 10% SDS^PAGE. After drying the gel, radioactivities
of phosphorylated p47phox^GST were measured with an imaging
analyzer.
2.9. Measurement of phagocytic activity
Phagocytosis of £uorescent latex particles by PMN was measured
by the following £ow cytometric technique. To prepare serum-opson-
ized £uorescent particles, £uorescent particles (1.0 Wm diameter) were
suspended in fresh autologous serum and incubated for 30 min at
37‡C. After incubation, the suspension was washed twice with
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HBSS(3) and resuspended in HBSS(3) at a concentration of 1U108
particles/ml. 200 Wl of HBSS(+) containing 2U106 PMN was prein-
cubated for 5 min at 37‡C. Then, 100 Wl of suspension containing
opsonized particles was added to this preincubated cell suspension
(cell :particle = 1:5) and the mixture was further incubated for 30
min at 4‡C or 37‡C. After centrifugation at 1200 rpm for 10 min at
4‡C, the cells were washed and suspended in HBSS(3). The £uores-
cence of the particles in PMN was analyzed by £ow cytometry (EP-
ICS 752; Coulter Electronics, Hialeah, FL, USA). The PMN that
ingested the particles were gated by excluding the counts of free par-
ticles.
3. Results
3.1. Activation of p38 MAPK, PKC and PI3-K of PMN
induced by sOZ stimulation
To determine whether sOZ could activate p38 MAPK, PKC
and PI3-K of PMN, phosphorylation of p38 MAPK, PKC
translocation from cytosol to membrane, and PI3-K activity
were assessed. The time course for the activation of these
three kinases after sOZ stimulation is shown in Fig. 1. A slight
increase of p38 MAPK phosphorylation was found at 3 min,
reaching the maximum at 6 min after stimulation. This phos-
phorylation was gradually decreased toward 12 min (Fig. 1A).
After stimulation, PKC translocation became apparent at
3 min and remained elevated up to 12 min (Fig. 1B). PI3-K
activation was clearly observed at 3 min and peaked at 6 min
(Fig. 1C). These results indicated that the sOZ stimulation
induced the activation of p38 MAPK, PKC and PI3-K of
PMN.
3.2. E¡ects of inhibitors on O32 production
Fig. 2 shows O32 production from sOZ-stimulated PMN
with and without inhibitors. Stimulation of PMN without
inhibitors elicited a time-dependent increase of O32 produc-
tion, which peaked at 6 min followed by a gradual decrease
(closed circles in Fig. 2). To investigate the involvement of p38
MAPK, PKC and PI3-K to the activation of NADPH oxi-
Fig. 1. Time course of activation of p38 MAPK, PKC and PI3-K
in sOZ-stimulated PMN. PMN were incubated for 5 min at 37‡C
prior to stimulation with 1 mg/ml of sOZ. After stimulation for the
indicated times at 37‡C, activation of each kinase was evaluated as
described in the text. A: Time course of p38 MAPK phosphory-
lation. B: Time course of PKC translocation. C: Time course of
PI3-K activation. The positions of phosphorylated phosphatidylino-
sitol and origin are marked by PIP and Ori., respectively.
Fig. 2. Time course of O32 production and the e¡ects of three inhib-
itors on it. O32 production was measured by chemiluminescence as
described in the text. PMN were incubated with an inhibitor for
5 min at 37‡C prior to stimulation with 1 mg/ml of sOZ at 37‡C.
Each point in the time course represents the mean of three experi-
ments. The concentrations of inhibitors were as follows:
(A) SB203580, 0 (b), 1 (E), 10 (O), 100 WM (a) ; (B) GF109203X,
0 (b), 1 (E), 4 (O), 8 WM (a) ; (C) wortmannin, 0 (b), 0.5 (E),
5 (O), 50 nM (a).
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dase, we examined the e¡ects of pharmacological inhibitors,
an inhibitor of p38 MAPK (SB203580), an inhibitor of PKC
(GF109203X) and an inhibitor of PI3-K (wortmannin), on
O32 production. All inhibitors dose-dependently reduced the
O32 production (Fig. 2). Thus, we concluded that NADPH
oxidase activation by sOZ requires activation of p38
MAPK, PKC and PI3-K.
3.3. E¡ects of inhibitors on p47phox phosphorylation
O32 production requires NADPH oxidase activation which
further requires the phosphorylation of p47phox, one of the
cytosolic oxidase components. This phosphorylation is consid-
ered to be a trigger for the assembly of cytosolic components
to the membrane components [2,24^26]. In fact, as shown in
Fig. 3A, sOZ stimulation of PMN time-dependently induced
the phosphorylation of p47phox^GST. The phosphorylating
activity of the cytosolic fraction of PMN was slightly in-
creased at 5 min and then reached a maximum at 10 min after
stimulation. We next examined the ability of kinases in the
cytosol fraction with or without various inhibitors. Lanes 1
and 2 in Fig. 3B show autoradiographs of p47phox^GST
phosphorylated by cytosol fractions obtained from untreated
PMN and PMN stimulated with sOZ for 7 min, respectively.
A signi¢cant increase of phosphorylated p47phox was ob-
served in sOZ-stimulated PMN. Furthermore, the phosphor-
ylation of p47phox was inhibited by all inhibitors. However,
the inhibitory e¡ects were di¡erent among them. 100 WM
SB203580 (lane 3) and 8 WM GF109203X (lane 4) largely
inhibited the phosphorylation of p47phox, whereas 50 nM
Fig. 3. In vitro phosphorylation of p47phox^GST induced by the
cytosolic fraction of sOZ-stimulated PMN. Phosphorylation of
p47phox^GST was measured as described in the text. A: Time
course of phosphorylation of p47phox^GST. B: The e¡ects of three
inhibitors on p47phox phosphorylation. PMN were incubated with
an inhibitor for 5 min at 37‡C prior to stimulation with 1 mg/ml of
sOZ for 7 min at 37‡C. (1) No stimulation with sOZ, (2) stimulated
with sOZ in the absence of an inhibitor, (3) stimulated with sOZ in
the presence of 100 WM SB203580 (SB), (4) stimulated with sOZ in
the presence of 8 WM GF109203X (GFX), (5) stimulated with sOZ
in the presence of 50 nM wortmannin (wtmn). Autoradiographs of
phosphorylated p47phox^GST are shown.
C
Fig. 4. The e¡ects of three inhibitors on phagocytosis. A^E: Repre-
sentative £ow cytometric pro¢les. PMN were incubated with serum-
opsonized £uorescent particles for 30 min (A) at 4‡C without inhibi-
tor, (B) at 37‡C without inhibitor, and (C^E) at 37‡C with inhibi-
tor. In these pharmacological experiments, PMN were incubated in
the presence of the inhibitor for 5 min at 37‡C prior to addition of
particles. C: 100 WM SB203580 (SB); D: 8 WM GF109203X
(GFX); E: 50 nM wortmannin (wtmn). F: Summary of phagocyto-
sis expressed as the percentage of PMN containing £uorescent par-
ticles against total cells. The results are expressed as the mean þ S.D.
of three experiments.
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wortmannin moderately reduced it (lane 5), though this dose
of wortmannin completely inhibited O32 production as the
others did. These data indicate that the reduction of O32 pro-
duction by p38 MAPK and PKC inhibitors is explained by
their inhibitory activity to p47phox, whereas the reduction of
O32 production by the PI3-K inhibitor is not fully explained
by its inhibitory activity to p47phox. PI3-K may participate in
other signaling pathways leading to the activation of NADPH
oxidase.
3.4. Roles of p38 MAPK, PKC and PI3-K in phagocytosis
To investigate the roles of these kinases in phagocytosis, we
examined the e¡ects of inhibitors on phagocytosis in PMN.
Phagocytic activity was evaluated by PMN that ingested se-
rum-opsonized £uorescent latex particles with £ow cytometry.
Fig. 4A,B show the £ow cytometric pro¢les obtained from
PMN incubated in the presence of £uorescent particles for
30 min at 4‡C and 37‡C, respectively. A highly £uorescent
cell population, indicating phagocytic PMN, appeared in the
£ow cytometric pro¢le at 37‡C without any inhibitor as
shown in Fig. 4B. These phagocytic cells disappeared com-
pletely after treatment with 100 WM SB203580 (Fig. 4C,F)
and were suppressed about 33% by 50 nM wortmannin
(Fig. 4E,F). By contrast, treatment of PMN with 8 WM
GF109203X facilitated the phagocytic activity (Fig. 4D,F).
These results led us to conclude that p38 MAPK and PI3-K
are deeply involved in the signaling pathway of phagocytosis
and that PKC is inversely involved in it.
4. Discussion
Zymosan and latex particles used as stimuli in this study
were opsonized by serum. These particles bound with IgG and
iC3b were considered to be able to bind FcQR and CR3,
respectively, followed by the induction of physiological re-
sponses. It was reported that cross-linking of FcQRs induced
activation of PI3-K accompanied by activation of tyrosine
kinases in U937 cells and PMN [8,16]. Several papers have
shown that the inhibition of PI3-K attenuated NADPH oxi-
dase activity, phosphorylation of p47phox in PMN stimulated
by fMLP, and phagocytosis of IgG-coated erythrocytes in
PMN [16,17]. In the present study we con¢rmed that PI3-K
was involved in both signaling pathways leading to NADPH
oxidase activation and phagocytosis induced by stimulation
with FcQR and CR3.
The importance of PKC on PMN responses is already well
known. Phorbol myristate acetate, a direct activator of PKC,
promotes the phosphorylation and translocation of p47phox
as the initial step for NADPH oxidase activation [2,24^26]. In
this study, we showed that PKC was an important factor in
NADPH oxidase activation and that its inhibition facilitated
phagocytosis. These di¡erent responses of PMN to PKC acti-
vation indicated that PKC played di¡erent roles in the signal-
ing pathways of NADPH oxidase activation and phagocytosis
in bovine PMN. However, PKC inhibition has been reported
to prevent phagocytosis in monocytes and PMN but not in
macrophages in humans [6,11,14]. Therefore, the role of PKC
in phagocytosis may be dependent on the cell type and/or
species. Further research is required to solve this discrepancy.
Because FcQR and CR3 stimulation with sOZ induced p38
MAPK activation and both O32 production and p47phox
phosphorylation were inhibited by SB203580, it is obvious
that p38 MAPK is involved in the p47phox phosphorylation
or upstream of it.
Concerning the mechanism of p38 MAPK-mediated phago-
cytosis, one possible target of p38 MAPK can be inferred to
be MAPK-activating protein kinase-2, a Ser/Thr kinase that
possesses the ability to phosphorylate small heat shock pro-
tein HSP27 [28] since HSP27 was reported to modulate actin
micro¢lament dynamics [29] and the actin polymerization is
known to be essential for phagocytosis [30]. Therefore, it
seems possible to speculate that the inhibition of phagocytosis
by SB203580 is due to impairment of p38 MAPK-mediated
phosphorylation of HSP27. Additionally, it was reported that
wortmannin prevented p38 MAPK activation in PMN and
di¡erentiated HL-60 cells stimulated by fMLP [27,28]. These
data suggest that PI3-K exists upstream of p38 MAPK.
In conclusion, we showed the importance and the di¡erent
roles of p38 MAPK, PKC and PI3-K in the signaling path-
ways of O32 production and phagocytosis in PMN. p38
MAPK and PI3-K participated in both signaling pathways
of O32 production and phagocytosis stimulated with FcQR
and CR3, and PKC participated in the signaling pathway of
O32 production alone. The distinct role of each enzyme in O
3
2
production and phagocytosis is important to understand the
signaling pathways of bactericidal responses in PMN.
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